Hervé Ajouc

Pernod Ricard (Paris)
Legal Director

Hervé Ajouc is Legal Director for Havana Club at Pernod Ricard. He previously worked within the Antitrust and Competition Law practice group of Darrois Villey Maillot Brochier’s office in Paris and the EU competition group of White & Case’s office in Brussels and has trained in the competition departments of Cleary Gottlieb Steen & Hamilton in Brussels, and CMS Bureau Francis Lefebvre in Paris. He has also completed internships at the European Commission’s Legal Service and the Court of Justice in Luxembourg (Cabinet of Judge J.C. Bonichot). Hervé’s practice focuses primarily on EU and French competition law and in particular on antitrust matters, state aid and litigation before the EU courts. He graduated with honors from the University of Paris II Panthéon-Assas (Master in European litigation) in 2007 and has been admitted to the Paris Bar in 2010. He speaks fluent French, English, Spanish and Italian.


3167 Bulletin

Hervé Ajouc, Jaime Garcia-Nieto The Spanish Supreme Court annuls a judgment from the Appellate Administrative Court and quashes a decision of the Competition Authority that imposed a substantial fine on powers generating companies for abusing their dominant position in the electricity market for technical restrictions (Unión Fenosa)


In a judgment delivered on January 27, 2010, the Spanish Supreme Court annulled a judgment of the Appellate Administrative Court of May 23, 2007 and quashed a Decision of July 7, 2004 of the Spanish Competition Authority (“NCA”) imposing a substantial fine on several power generating companies (...)

Hervé Ajouc, Jaime Garcia-Nieto The Spanish Supreme Court provides guidance on the application of the proof by presumptions test in the context of a bid rigging case in the healthcare sector (Amersham Health)


On October 3, 2009, the Spanish Supreme Court (Tribunal Supremo) quashed the Appellate Administrative Court’s (Audiencia Nacional) judgment of April 11, 2006 upholding a decision of the Spanish competition authority (“NCA”) to fine four healthcare companies for bid-rigging on the market for the (...)

Send a message